NCT07306559
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07306559
Title A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
Valkyrie Clinical Trials RECRUITING Los Angeles California 90067 United States Details
Indiana University NOT_YET_RECRUITING Indianapolis Indiana 46202 United States Details
The University of Texas MD Anderson Cancer Center NOT_YET_RECRUITING Houston Texas 77030 United States Details
Cliniques Universitaires Saint-Luc NOT_YET_RECRUITING Brussels 1200 Belgium Details
UZ Leuven SUSPENDED Leuven 3000 Belgium Details
INS Paoli-Calmettes NOT_YET_RECRUITING Marseille 13009 France Details
Institut Gustave Roussy NOT_YET_RECRUITING Villejuif 94800 France Details
Klinikum der Universität München AÖR NOT_YET_RECRUITING München 81377 Germany Details
Universitätsklinikum Würzburg AÖR NOT_YET_RECRUITING Würzburg 97078 Germany Details
National Cancer Center Hospital East NOT_YET_RECRUITING Chiba, Kashiwa 277-8577 Japan Details
Japanese Foundation for Cancer Research NOT_YET_RECRUITING Tokyo, Koto-ku 135-8550 Japan Details
Hospital Universitari Vall D Hebron NOT_YET_RECRUITING Barcelona 08035 Spain Details
Clínica Universidad de Navarra - Madrid NOT_YET_RECRUITING Madrid 28027 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field